Pharmaceutical

EC approves Astellas’ PADCEV for urothelial cancer

The European Commission has authorised Astellas Pharma's PADCEV regimen for the ...

Pfizer launches digital healthcare platform to streamli...

Pfizer has launched a new digital platform, PfizerForAll, aimed at simplifying t...

Eli Lilly’s Zepbound to be issued in single-dose vials ...

Eli Lilly has announced the availability of Zepbound (tirzepatide) in 2.5mg and ...

UCB to divest China neurology and allergy business for ...

UCB has entered a divestment agreement in China to sell its mature neurology and...

MSD snags European approval for pulmonary arterial hype...

Winrevair is the first approved activin signaling pathway-targeting therapy for ...

Celltrion’s SteQeyma receives EC approval for chronic i...

The European Commission (EC) has approved Celltrion's SteQeyma, a biosimilar to ...

Invenra’s antibody gains US FDA designations for neurob...

Invenra received rare pediatric disease designation (RPDD) and orphan drug desig...

China NMPA grants approval for GenFleet’s fulzerasib to...

China has granted approval for GenFleet Therapeutics’ fulzerasib for advanced no...

Janssen’s BALVERSA receives EC approval for metastatic ...

The European Commission (EC) has approved Janssen's BALVERSA as a treatment for ...

AstraZeneca may pull plug on UK vaccine manufacturing p...

AstraZeneca may relocate its vaccine manufacturing plans from the UK to US as th...

Eli Lilly doubles down on Oblique partnership for antib...

The two companies have expanded their agreement first inked in 2023, with a seco...

Jazz’s cannabidiol therapy flunks in Japanese Phase III...

Jazz’s cannabidiol oral solution, Epidiolex, is approved as an adjunct seizure t...

A comprehensive guide to supply chain management for sp...

Integrating sustainable solutions within supply chains is imperative to ensure l...

Rafael Holdings and Cyclo Therapeutics enter merger deal

Rafael Holdings has signed a definitive merger agreement with Cyclo Therapeutics...

VION Biosciences acquires Echelon Biosciences

VION Biosciences has announced the acquisition of Echelon Biosciences, known for...

FDA approves updated mRNA vaccines for Covid-19

The US FDA has approved and granted EUA for Moderna and Pfizer-BioNTech’s update...